"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL
"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL
Recruiting · NCT06559553 · Registry updated 2025-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| "Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL | extranodal nasal NK/T cell lymphoma | Recruiting | Phase 1 / Phase 2 | 2025-07-14 | NCT06559553 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mingzhi Zhang | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oncology Department of The First Affilliated Hospital of Zhengzhou University | Zhengzhou | China | 2 |